Removal and degradation of sodium diclofenac via radical-based mechanisms using S. sclerotiorum laccase

J Inorg Biochem. 2023 Dec:249:112400. doi: 10.1016/j.jinorgbio.2023.112400. Epub 2023 Oct 11.

Abstract

The recently isolated Sclerotinia sclerotiorum laccase was used for the degradation of sodium diclofenac, a nonsteroidal anti-inflammatory drug widely found in the aquatic environment. The Michaelis-Menten parameters, half-life of diclofenac at different pH values in presence of this enzyme and potential inhibitors were evaluated. Diclofenac-based radicals formed in presence of laccase were spin-trapped and detected using EPR spectroscopy. Almost complete diclofenac degradation (> 96%) occurred after a 30-h treatment via radical-based generated oligomers and their rapid precipitation, thus ensuring an unprecedented green formula suitable not only for degradation but also for straightforward removal of the degradation products. High performance liquid chromatography coupled with atmospheric pressure chemical ionization-ion trap mass spectrometry (HPLC-APCI-MS) analyses of the degradation products of diclofenac in aqueous dosage revealed the presence of at least seven products while HR Orbitrap MS analysis showed that the enzymatic treatment produced high molecular weight metabolites through a radical oligomerization mechanism of diclofenac. The enzymatically formed products precipitated and its constituting components were also characterized using UV-vis spectroscopy, infrared spectroscopy (FTIR) and thermogravimetric analysis (TGA).

Keywords: DFT; Degradation; Diclofenac; HPLC-MS; Laccase; UV–Vis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Chromatography, High Pressure Liquid
  • Diclofenac* / chemistry
  • Laccase* / metabolism

Substances

  • Diclofenac
  • Laccase
  • Anti-Inflammatory Agents, Non-Steroidal